Dunia Llapur Hernandez
Internal Medicine · Miami, FLNPI 1285052043
Payments from drug & device makers
What this record shows
5 manufacturers reported payments, led by Eli Lilly at 51.7% of the total. 2024 is the largest year on record at $1,518, more than ten times the $54 reported in 2019.
Across 15 payments — averaging $107.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$830
- Pfizer$699
- Novo Nordisk$39
- Boehringer Ingelheim$22
- Bayer$17
Across 364 payments — averaging $12,080 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.8M
- Boehringer Ingelheim$898K
- Pfizer$615K
- AbbVie$564K
- Amgen$266K
- Vanda Pharmaceuticals Inc.$109K
- plus $148K from 3 others
What the payments were for
- Travel & lodging$91257%
- Food & beverage$69443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 7 | $830 |
| Pfizer | 4 | $699 |
| Novo Nordisk | 2 | $39 |
| Boehringer Ingelheim | 1 | $22 |
| Bayer | 1 | $17 |
How this compares
$1,606 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Miami
- Haytham ElgammalMiami$2.2M
- Richard AguilarMiami$239K
- Maria Delgado LelievreMiami$80K
- Marlow HernandezMiami$58K
- Steven CohnMiami$47K
- Joseph PiperatoMiami$45K
- Simon AbelsonMiami$44K
- Joel Brooks TamayoMiami$42K
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.